IP Library Granted Patent US 10,072,260
Granted Patent B2
US 10,072,260 · App. 14/649,494 · Granted Sep 11, 2018

Target enrichment of randomly sheared genomic DNA fragments

Inventors: Scott Robert Happe (Austin, TX); Emily Marine Leproust (San Jose, CA); Julia Barboza (Austin, TX); Joseph Hoang Hai Ong (Austin, TX)
Assignee: AGILENT TECHNOLOGIES, INC.
C12N15/1068C12Q1/6806
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,072,260
App. No.
14/649,494
Granted
Sep 11, 2018
Kind
B2
Abstract

Provided herein are various methods for enriching a target fragment that is present in randomly sheared genomic DNA. In some embodiments, the method may involve hybridizing randomly sheared genomic DNA to a halo probe to produce a first circular complex, and then enzymatically digesting the overhanging ends of the genomic fragment. Other embodiments may include hybridizing randomly sheared genomic DNA to an RNA oligonucleotide that comprises a region that hybridizes to a fragment of the randomly sheared genomic DNA to produce an RNA/DNA duplex. The overhanging ends of the genomic fragment in the RNA/DNA duplex can then be enzymatically digested.

Claims (19)

1. A method comprising:

(a) hybridizing randomly sheared genomic DNA to a halo probe to produce a first circular complex, wherein said halo probe comprises:

(i) a first oligonucleotide comprising flanking sequences that hybridize to different regions in a fragment of the randomly sheared genomic DNA and a central sequence: and

(ii) one or more second oligonucleotides that are complementary to the central sequence of the first oligonucleotide;

(b) enzymatically digesting the overhanging ends of the genomic fragment in the first circular complex to provide a second circular complex in which 5′ and 3′ ends of the one or more second oligonucleotide are ligatably adjacent to the 3′ and 5′ ends of the digested genomic fragment; and

(c) ligating the ends of the digested genomic fragment of (b) to the ends of the one or more second oligonucleotide to produce a circular DNA molecule.

2. The method of claim 1 , wherein said method comprises:

(d) amplifying the digested genomic fragment from said circular DNA molecule using one or more primers that bind to sites that are provided by the one or more second oligonucleotides.

3. The method of claim 2 , further comprising:

(e) sequencing the amplification product of (d) to provide the nucleotide sequence of at least part of the digested genomic fragment.

4. The method of claim 1 , wherein said first oligonucleotide comprises a capture moiety and wherein said method comprises, between steps (a) and (b), isolating said first circular complex using said capture moiety.

5. The method of claim 3 , wherein said sequencing is done using prime that hybridize to sequencing primer sites in said one or more second oligonucleotides.

6. The method of claim 1 , wherein said enzymatically digesting comprises digesting said first circular complex using a single-strand specific bi-directional exonuclease, in the optional presence of a polymerase.

7. The method of claim 6 , wherein said single-strand specific bi-directional exonuclease is exonuclease VII.

8. The method of claim 1 , wherein said enzymatically digesting comprises treatment with a Pfu DNA polymerase/Taq DNA polymerase cocktail, or T4 DNA polymerase/exonuclease VII cocktail, treatment with a mung bean nuclease, or treatment with a flap endonuclease in combination with another 3′ endonuclease.

9. The method of claim 1 , wherein the randomly sheared genomic DNA is produced from genomic DNA using chemical, physical or transposase-catalyzed fragmentation methods.

10. The method of claim 9 , wherein said physical fragmentation methods comprise sonication, nebulization, or shearing.

11. The method of claim 1 , wherein said one or more second oligonucleotides is a single oligonucleotide that is complementary to the central sequence of the first oligonucleotide.

12. The method of claim 1 , wherein said one or more second oligonucleotides is two oligonucleotides, each comprises a first region that hybridizes to said first oligonucleotide, and a second region that provides binding sites for one or more amplification primers.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 4, 2015
From: LEPROUST, EMILY MARINE; HAPPE, SCOTT; BARBOZA, JULIA; ONG, JOSEPH HOANG HAI
To: AGILENT TECHNOLOGIES, INC.
Reel/Frame 035788/0400 →
Continuity (2)
Provisional Application 61734251 · Dec 6, 2012
Related Publication 20150307875A1 · Oct 29, 2015
Cited By (6)
US 12,359,193 US 12,365,892 US 12,371,743 US 12,469,162 US 12,505,571 US 12,606,819